Cortes et al., 2018 - Google Patents
RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesisCortes et al., 2018
View HTML- Document ID
- 1020684286148905271
- Author
- Cortes J
- Ambesi-Impiombato A
- Couronné L
- Quinn S
- Kim C
- da Silva Almeida A
- West Z
- Belver L
- Martin M
- Scourzic L
- Bhagat G
- Bernard O
- Ferrando A
- Palomero T
- Publication year
- Publication venue
- Cancer cell
External Links
Snippet
Angioimmunoblastic T cell lymphoma (AITL) is an aggressive tumor derived from malignant transformation of T follicular helper (Tfh) cells. AITL is characterized by loss-of-function mutations in Ten-Eleven Translocation 2 (TET2) epigenetic tumor suppressor and a highly …
- 101700020165 RHOA 0 title abstract description 233
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cortes et al. | RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis | |
| Srivastava et al. | Immunogenic chemotherapy enhances recruitment of CAR-T cells to lung tumors and improves antitumor efficacy when combined with checkpoint blockade | |
| Alam et al. | Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer | |
| Gunderson et al. | TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking | |
| Śledzińska et al. | Regulatory T cells restrain interleukin-2-and Blimp-1-dependent acquisition of cytotoxic function by CD4+ T cells | |
| Ma et al. | Interleukin-23 engineering improves CAR T cell function in solid tumors | |
| Meyer et al. | Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance | |
| Daley et al. | γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation | |
| Tu et al. | T cell receptor-regulated TGF-β type I receptor expression determines T cell quiescence and activation | |
| Raeber et al. | Interleukin-2 signals converge in a lymphoid–dendritic cell pathway that promotes anticancer immunity | |
| Turnis et al. | Interleukin-35 limits anti-tumor immunity | |
| Harper et al. | Regulation of the anti-tumour immune response by cancer-associated fibroblasts | |
| Wu et al. | The tuberous sclerosis complex–mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells | |
| Secondini et al. | Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade | |
| Nixon et al. | TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective | |
| MacDonald et al. | Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10 | |
| Zhang et al. | Type 1 conventional dendritic cell fate and function are controlled by DC-SCRIPT | |
| Özcan et al. | CCR7-guided neutrophil redirection to skin-draining lymph nodes regulates cutaneous inflammation and infection | |
| Cortes et al. | Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma | |
| Wang et al. | Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death | |
| Tenno et al. | Cbfβ2 deficiency preserves Langerhans cell precursors by lack of selective TGFβ receptor signaling | |
| Lu et al. | STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells | |
| Li et al. | Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma | |
| Tabasum et al. | EDIL3 as an angiogenic target of immune exclusion following checkpoint blockade | |
| McNamara et al. | Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8+ T cells |